ORPHAZYME A/S - ADR (ORPH)
ADR
ORPHAZYME A/S - ADR
NASDAQ:ORPH (3/30/2022, 8:50:21 PM)
After market: 0.8002 -0.07 (-8.02%)0.87
-0.02 (-2.25%)
Company Profile
Orphazyme A/S is a biopharmaceutical company, which engages in the development of treatment for patients living with life-threatening and debilitating rare diseases. The company develops new therapies for the treatment of a family of genetic disorders. The firm's main focus is on preclinical development of medicines for the treatment of lysosomal storage diseases (LSDs), a group of approximately 50 genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, and protein aggregation diseases. The Company’s candidate, arimoclomol, stimulates the production of the cells’ protein rescue system, the heat shock proteins, which helps the misfolded proteins to either get back to their functional shape or, if this cannot be achieved, remove them from the cells by means of the cells’ recycling system, the lysosomes, so they no longer form toxic aggregates. The firm collaborates with academic institutions in Europe and the United States.
Company Info
ORPHAZYME A/S - ADR
Ole Maaloees Vej 3, Copenhagen N
KOEBENHAVN DK-2200
P: 4539178272.0
CEO: Anders Vadsholt
Employees: 180
Website: https://www.orphazyme.com/
ORPH News
2 years ago - InvestorPlaceDear ORPH Stock Fans, Mark Your Calendars for March 31After Orphazyme announced that it would withdraw the application for approval of its drug and delist its ADSs, ORPH stock is falling.
2 years ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayGrab your cup of coffee, investor! We're starting off the day with a dive into the biggest pre-market stock movers for Tuesday!
2 years ago - InvestorPlaceWhy Is OXY Stock Up Today? Does Warren Buffett’s Berkshire Want to Buy Occidental Petroleum?Occidental Petroleum (OXY) stock is rising higher on Thursday following news that Berkshire Hathaway increased its stake in the company.
2 years ago - InvestorPlaceWhy Is Orphazyme (ORPH) Stock Up Today?The troubled biotech company's share price is up 40% despite plans to delist from the Nasdaq exchange and lay off 50% of its workers.
2 years ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayGood morning, traders! We're starting the final day of the workweek with a look at the biggest pre-market stock movers for Friday!
ORPH Twits
Here you can normally see the latest stock twits on ORPH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
